Burden of Stroke in Italy: An Economic Model Highlights Savings Arising from Reduced Disability following Thrombolysis

Author:

Chiumente M.1,Gianino M. M.2,Minniti D.3,Mattei T. J.4,Spass B.5,Kamal K. M.4,Zimmerman D. E.4,Muca A.2,Luda E.6

Affiliation:

1. Post Graduate School of Hospital Pharmacy, University of Turin, Turin, TO, Italy

2. Department of Public Health and Paediatrics Sciences, University of Turin, Turin, TO, Italy

3. Medical Direction, Rivoli Hospital, Rivoli, TO, Italy

4. Division of Clinical, Social and Administrative Sciences, Duquesne University, Mylan School of Pharmacy, Duquesne, PA, USA

5. Division of Neurology – The Hospital of Central Connecticut, New Britain, CT, USA

6. Neurology Department, Rivoli Hospital, Rivoli, TO, Italy

Abstract

Background The consequences of stroke must be assessed not only in terms of incidence and mortality rates, but also in terms of disability, which may persist long after the acute phase. Thrombolysis, if timely administered, can effectively reduce post-stroke disability. Aims The economic model presented herein aims to evaluate, in eligible patients, the effects of alteplase on post-stroke disability and related costs over three-years. Methods The economic analysis was developed on the basis of four key components: clinical outcomes from international trials, economic consequences extracted from cost of illness studies, regulatory data from national and international agencies, and national epidemiological data. A population-level model estimated the difference in disability costs between patients treated with standard care versus those receiving thrombolytic therapy within 4×5 h of acute ischemic stroke. The analysis covered 36 months from discharge. Results Reduced costs related to post-stroke disability were observed in treated patients compared with those receiving standard care (control). The overall savings were ¢2330×15 per average patient: ¢1445×81 during the first 18 months, ¢362×25 between 18 and 24 months, and ¢522×09 in the 24–36 months period. The overall savings on 3174 Italian treated patients in 2013 were ¢7 395 907 over three-years. Conclusion Our study reveals that performing thrombolytic therapy in eligible patients improves economic outcomes compared with patients receiving standard care. This model is useful for decision makers, both within and outside of the Italian national context, as a tool to assess the cost-effectiveness of thrombolysis in both short- and long-term period.

Publisher

SAGE Publications

Subject

Neurology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3